Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) and NLS Pharmaceutics (NASDAQ:NCEL – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? Analyst RecommendationsThis is a breakdown of recent ratings and price targets for Eupraxia Pharmaceuticals and NLS Pharmaceutics, as reported by MarketBeat.com. Given NLS Pharmaceutics’ higher probable upside, analysts clearly believe NLS Pharmaceutics is more favorable than Eupraxia Pharmaceuticals. ProfitabilityThis table compares Eupraxia Pharmaceuticals and NLS Pharmaceutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Eupraxia Pharmaceuticals N/A -87.56% -51.20% NLS Pharmaceutics N/A N/A N/AAbout Eupraxia Pharmaceuticals(Get Free Report)Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company.